AZTR stock icon

Azitra
AZTR
Market cap $3.84M

0.5036 USD
+0.0036
0.72%
At close Oct 4, 4:00 PM EDT
After hours
0.5019
-0.0017
0.34%
1 day
0.72%
5 days
-12.39%
1 month
-15.08%
3 months
-77.81%
6 months
-92.89%
Year to date
-98.40%
1 year
-98.84%
5 years
-99.66%
 

About: Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

Employees: 10

0
Funds holding %
of 6,728 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

3.28% less ownership

Funds ownership: 5.35% [Q1] → 2.07% (-3.28%) [Q2]

33% less funds holding

Funds holding: 12 [Q1] → 8 (-4) [Q2]

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

82% less capital invested

Capital invested by funds: $316K [Q1] → $58.5K (-$258K) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for AZTR.

Financial journalist opinion

Based on 3 articles about AZTR published over the past 30 days

Charts implemented using Lightweight Charts™